300 related articles for article (PubMed ID: 1649314)
1. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.
Chang YN; Dong DL; Hayward GS; Hayward SD
J Virol; 1990 Jul; 64(7):3358-69. PubMed ID: 2161945
[TBL] [Abstract][Full Text] [Related]
3. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
Kolman JL; Taylor N; Gradoville L; Countryman J; Miller G
J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
Sato H; Takeshita H; Furukawa M; Seiki M
J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos.
Flemington E; Speck SH
J Virol; 1990 Sep; 64(9):4549-52. PubMed ID: 2166830
[TBL] [Abstract][Full Text] [Related]
6. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.
Farrell PJ; Rowe DT; Rooney CM; Kouzarides T
EMBO J; 1989 Jan; 8(1):127-32. PubMed ID: 2540954
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
9. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.
Kouzarides T; Packham G; Cook A; Farrell PJ
Oncogene; 1991 Feb; 6(2):195-204. PubMed ID: 1847997
[TBL] [Abstract][Full Text] [Related]
10. Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.
Heston L; El-Guindy A; Countryman J; Dela Cruz C; Delecluse HJ; Miller G
J Virol; 2006 Sep; 80(18):9115-33. PubMed ID: 16940523
[TBL] [Abstract][Full Text] [Related]
11. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
[TBL] [Abstract][Full Text] [Related]
12. Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.
Flemington E; Speck SH
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9459-63. PubMed ID: 2174563
[TBL] [Abstract][Full Text] [Related]
13. Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.
Kolman JL; Taylor N; Marshak DR; Miller G
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10115-9. PubMed ID: 8234266
[TBL] [Abstract][Full Text] [Related]
14. Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins.
Ransone LJ; Wamsley P; Morley KL; Verma IM
Mol Cell Biol; 1990 Sep; 10(9):4565-73. PubMed ID: 2143806
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
Sista ND; Pagano JS; Liao W; Kenney S
Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
[TBL] [Abstract][Full Text] [Related]
16. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
Cohen DR; Curran T
Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
[TBL] [Abstract][Full Text] [Related]
17. The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.
Kenney SC; Holley-Guthrie E; Quinlivan EB; Gutsch D; Zhang Q; Bender T; Giot JF; Sergeant A
Mol Cell Biol; 1992 Jan; 12(1):136-46. PubMed ID: 1309587
[TBL] [Abstract][Full Text] [Related]
18. The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence.
Mikaélian I; Drouet E; Marechal V; Denoyel G; Nicolas JC; Sergeant A
J Virol; 1993 Feb; 67(2):734-42. PubMed ID: 8380464
[TBL] [Abstract][Full Text] [Related]
19. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
Flemington EK; Lytle JP; Cayrol C; Borras AM; Speck SH
Mol Cell Biol; 1994 May; 14(5):3041-52. PubMed ID: 8164660
[TBL] [Abstract][Full Text] [Related]
20. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
